Showing results (111-120 of 235) with videos related to

Sort By:
Pageof 24
Life (Basel, Switzerland)|September 9, 2020
"Primum Non Nocere" in Interventional Oncology for Liver Cancer: How to Reduce the Risk for Complications?Roberto Iezzi, Tiago Bilhim, Laura Crocetti, et al.
Anticancer Research|February 7, 2016
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II StudyRosa Autorino, Gian Carlo Mattiucci, Francesco Ardito, et al.
Surgical Endoscopy|March 4, 2020
Preoperative predictors of liver decompensation after mini-invasive liver resectionCarlo Sposito, Michela Monteleone, Luca Aldrighetti, et al.
Annals of Translational Medicine|July 19, 2021
Intensive multidisciplinary treatment strategies and patient resilience to challenge long-term survival in metastatic colorectal cancer: a case report in real life and clinical practiceGemma Bruera, Francesco Pepe, Umberto Malapelle, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 20, 2022
Survival by Number and Sites of Resections of Recurrence after First Curative Resection of Colorectal Liver MetastasesElena Panettieri, Bradford J Kim, Yoshikuni Kawaguchi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 23, 2019
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastasesValerio Gallotta, Carmine Conte, Marco D'Indinosante, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significancePier Paolo Claudio, Giuseppe Russo, Christine A C Y Kumar, et al.
Scientific Reports|November 23, 2021
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancerDonatella Lucchetti, Ina Valeria Zurlo, Filomena Colella, et al.
Cancers|August 12, 2023
Early-Stage HCC Percutaneous Locoregional Management: East versus West PerspectivesRoberto Iezzi, Alessandro Posa, Andrea Contegiacomo, et al.
The American Journal of Pathology|August 21, 2010
Prostate apoptosis response-4 is expressed in normal cholangiocytes, is down-regulated in human cholangiocarcinoma, and promotes apoptosis of neoplastic cholangiocytes when induced pharmacologicallyAntonio Franchitto, Alessia Torrice, Rossella Semeraro, et al.
Pageof 24